China Builds World’s Humanoids at Scale, but Buyers Lag
Chinese humanoid makers pursue scale and government contracts even as global buyers pull back, creating a rising back...
Volatile Periods Retirees Should Expect Sp 500
This article outlines typical volatile periods for SP 500 and how retirees can position portfolios to endure drawdowns while meeting needs.
26,423 articles
This Historically Cheap Cash Cow Signals Value and Growth
Alphabet stands out as a durable cash engine blending a near-monopoly ad business with AI-driven cloud gains, offerin...
China Controls Pivotal “AI” Chokepoint: Why America Can’t Fix Rare Earths Overnight
A new wave of policy and investment is aimed at loosening China’s grip on rare earth processing. Yet the bottleneck i...
Mexico City Roasts Chandeliers Amid World Cup Makeover
Mexico City's metro facelift for the World Cup has critics accusing officials of prioritizing aesthetics over essenti...
Prediction: Can Meta Stock Reach $700 by Year-End?
Meta Platforms faces a heavy AI investment cycle that could weigh on near-term cash flow, even as revenue climbs. Thi...
Economic News Piling Up: Recession Looms for Markets
May data showed a resilient job market amid softer growth signals, fueling fears that economic news piling recession ...
Semiconductor ETFs Dominate the Most-Traded List Again
Semiconductor ETFs are leading the charge on U.S. exchanges, pushing chip-focused funds onto the most-traded lists. T...
Standard Chartered’s $100 Uniswap Forecast Roils DeFi
Standard Chartered unveils a bold UNI price forecast for 2030, arguing tokenized assets will push DeFi liquidity to t...
Pending Home Sales Showed Strength as Rates Stabilize
May pending home sales showed a notable uptick despite higher borrowing costs. The NAR report shows gains across regi...
Two Big Reasons Accenture’s Stock Is Sliding This Week
Accenture posted solid earnings but offered a cautious outlook, prompting a market selloff. Analysts point to two mai...
Fed’s Warsh Still Expects a Rate Hike This Year, Next Moves
The Fed left its policy rate unchanged, but a veteran observer says the odds of a hike this year remain intact as War...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status